Please use this identifier to cite or link to this item:
Title: The fabrication of Co-Cr RPD for a hemi-maxillectomy defect
Authors: Fakie, Irshaad
Keywords: Ameloblastoma;Malignant tumour;Maxilla
Issue Date: 2003
Source: Fakie, Irshaad, "The fabrication of Co-Cr RPD for a hemi-maxillectomy defect" (2003). Tygerberg Dental Sciences. Paper 29.
Series/Report no.: Tygerberg Dental Sciences;Paper 29
Abstract: The patient is a 40 year old female. In January 2002 she was complaining about a large swelling of the right side of the face which causing a facial asymmetry. The swelling extended buccally and palatally in the first quadrant posteriorly of the maxilla. In March 2002, due to the aggressive swelling and pain the patient went to Hope Street Dental Clinic, x-rays were taken and she was given anti-biotic for the swelling and pain. In June 2002 the patient returns to Hope Street Dental Clinic where the 18 & 17 were extracted and they referred her to Grootte Schuur Hospital for further investigation and treatment. After investigation the surgeon discovered that the patient was suffering from Ameloblastoma. Ameloblastoma is a malignant tumour or a germ cell in the dentine and almost certainly arises from the enamel organ. The relatively common true tumour accounts for one per cent (1%) of all oral tumours. The tumours are normally active from the age of 33 years and 80% in the mandible, but in this case it appears in the maxilla.
Description: This Text is brought to you for free and open access by the Faculty of Health & Wellness Sciences at Digital Knowledge. It has been accepted for inclusion in Tygerberg Dental Sciences by an authorized administrator of Digital Knowledge.
Appears in Collections:Tygerberg Dental Sciences (Articles and Presentations)

Files in This Item:
File Description SizeFormat 
fulltext.pdf3.15 MBAdobe PDFView/Open
Show full item record

Page view(s)

Last Week
Last month
checked on Sep 19, 2018


checked on Sep 19, 2018

Google ScholarTM


Items in Digital Knowledge are protected by copyright, with all rights reserved, unless otherwise indicated.